Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Virtual Reality in the Treatment of Flying Phobia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01442805
Recruitment Status : Completed
First Posted : September 29, 2011
Last Update Posted : March 15, 2017
Sponsor:
Collaborator:
Centre Hospitalier du Luxembourg
Information provided by (Responsible Party):
Luxembourg Institute of Health

Brief Summary:

The project aims to explore the potential of Virtual Reality Exposure Therapy (VRET) for the treatment of the fear of driving, the fear of flying and the fear of public speaking.

The study is a randomized controlled trial (RCT) designed to compare the efficiency of cognitive behavioural therapy with exposures in imagination to behavioural therapy with exposures in virtual reality. Anxiety levels are measured using specific questionnaires, SUD ratings and physiological measures (heart rate, skin conductance, skin temperature, breathing frequency, heart rate variability).

Hypothesis: Treatments with exposures in virtual reality are more efficient than treatments with exposures in imagination.


Condition or disease Intervention/treatment Phase
Flying Phobia Behavioral: Virtual Reality Exposure Therapy Behavioral: Exposure Therapy through Imagination Not Applicable

Detailed Description:

In the past, several studies have demonstrated the effectiveness of virtual reality exposure therapy in the treatment of flying phobia and driving phobia. As an objective tool, psychophysiological recordings help demonstrate the decrease of physiological aspects of anxiety reactions (heart rate, skin conductance, skin temperature, heart rate variability and breathing pattern).

The aim of the present study is to examine the effects of cognitive behavioural therapy with exposures in imagination to behavioural therapy with exposures in virtual reality in the treatment of patients with flying phobia. Thirty patients will be randomized into either an imagination exposure group or a virtual reality exposure group after having received four sessions of cognitive behavioural therapy for coping with panic attacks. Respective exposure therapies consist in four sessions.

Anxiety levels will be measured before and after the cognitive behavioural therapy for coping with panic attacks as well as before and after the exposure therapy sessions and after 3 months using specific questionnaires, SUD ratings and psychophysiological measures (heart rate, skin conductance, skin temperature, breathing frequency and heart rate variability). The exposure stimuli will consist in a 10min movie of a flight with an insight-cabin viewing perspective.

The investigators hypothesize that virtual reality exposure therapies will be more effective than imagination exposure therapy in terms of decrease of anxiety self-ratings and psychophysiological fear reactions.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Etude contrôlée Des Effets de la réalité Virtuelle Sur Les symptômes et Les paramètres Physiologiques de Certaines Phobies spécifiques
Study Start Date : October 2008
Actual Primary Completion Date : September 2011
Actual Study Completion Date : March 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Phobias

Arm Intervention/treatment
Experimental: RV
Cognitive Behavioral Therapy with Virtual Reality Exposures
Behavioral: Virtual Reality Exposure Therapy
Participants are exposed to the feared situation (flying) through the virtual reality technology

Experimental: IMAGO
Cognitive Behavioral Therapy with Exposure Therapy through Imagination
Behavioral: Exposure Therapy through Imagination
Participants are exposed to the feared situation (flying) through exposure technique of imagination.




Primary Outcome Measures :
  1. Flight taken [ Time Frame: 6 months ]
    Participants are expected to take a real flight


Secondary Outcome Measures :
  1. Physiological Measures [ Time Frame: 6 months ]
    Heart Rate, Breathing frequency, Skin conductance, Skin Temperature, Heart Rate Variability

  2. Specific Questionnaires [ Time Frame: 6 months ]
    Specific Questionnaires: SUD, Motivational Scale, Fear Questionnaire Marks 1979, Sheehan Disability Scale, STAI I & II, BDI, BAI, GAF, Flight Anxiety Situations Questionnaire FAS, Flight Anxiety Modality Questionnaire FAM



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Confirmed diagnosis of a specific phobia (DSM-IV-TR)

Exclusion Criteria:

  • Pregnant women
  • Subjects with severe pulmonary / cardiovascular problems; Asthma, epilepsy, vertigo
  • Drug abuse
  • Subjects under on-stabilized anti-depressant treatment
  • Psychotic subjects
  • Subjects with suicidal ideas
  • Subjects presenting insufficient intellectual capabilities

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442805


Locations
Layout table for location information
Luxembourg
Centre de Recherche Public de la Santé
Strassen, Luxembourg, L-1445
Sponsors and Collaborators
Luxembourg Institute of Health
Centre Hospitalier du Luxembourg
Investigators
Layout table for investigator information
Principal Investigator: Charles Pull, Prof.Dr. Centre de Recherche Public de la Santé

Layout table for additonal information
Responsible Party: Luxembourg Institute of Health
ClinicalTrials.gov Identifier: NCT01442805     History of Changes
Other Study ID Numbers: 20080102
First Posted: September 29, 2011    Key Record Dates
Last Update Posted: March 15, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Luxembourg Institute of Health:
Cognitive Behavior Therapy
Virtual Reality Exposure Therapy
Psychophysiological Measures
Driving Phobia
Flying Phobia

Additional relevant MeSH terms:
Layout table for MeSH terms
Phobic Disorders
Anxiety Disorders
Mental Disorders